
Last Price
52 Week Range
$30.08 - $62.18
Next Earnings Date
-
Next Earnings Date
-
Last Price
Market Cap | $3.35B |
EV | $3.08B |
Shares Outstanding | 78.76M |
Beta | - |
Industry | Medical - Healthcare Information Services |
Analyst Rating | OUTPERFORM |
Analyst Target Price | |
Number of Analysts | 15 |
P/E E | - |
P/Revenue E | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin E | - |
Net Profit Margin E | - |
ROE E | - |
ROCE | - |
DPS E | - |
Payout Ratio E | - |
Div. Yield E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y

Hinge Health, Inc.
HNGE
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Perez, Daniel
Employees
1,437
Website
www.hingehealth.comIPO Date
2025-05-22
Headquarters
455 Market Street, Suite 700, San Francisco, California, 94105, United States
The current price of Hinge Health (HNGE) is $44.29, reflecting a +2.43% change compared to the previous close. Last updated: April 24, 2026 at 4:23 PM Eastern Time
Review of Recent HNGE Stock Performance trends:Past 1 Month: Hinge Health (HNGE) shares changed by +2.68%.Past 3 Months: The stock recorded a change of +1.60%.Past 6 Months: HNGE shares posted a change of -12.73%. Last updated: April 23, 2026 at 6:09 PM Eastern Time
Over the last year, Hinge Health (HNGE) has established a 52-week price range between a high of $62.18 and a low of $30.08. This metric is essential for assessing the stock's annual volatility. Last updated: April 23, 2026 at 6:09 PM Eastern Time
Based on current HNGE analyst forecasts, the consensus price target for Hinge Health (HNGE) is $57.53 for 2027. Relative to the current price of $44.29, this implies a positive upside of +33.06%. Price targets reflect forward-looking estimates based on information available at the time and are inherently subject to change as underlying assumptions, company fundamentals, or market conditions evolve. Last updated: April 24, 2026 at 4:23 PM Eastern Time
The current Hinge Health (HNGE) market capitalization is approximately $3.35B, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Hinge Health's market cap fluctuates with changes in its share price and share count. Last updated: April 23, 2026 at 6:09 PM Eastern Time
Hinge Health's (HNGE) earnings reports, including quarterly and annual financial statements, are available through the company's official regulatory filings with the U.S. Securities and Exchange Commission (SEC). On Gainify, you can access Hinge Health's full set of filings, including earnings releases, Form 10-Q, Form 10-K, and other disclosures, in one place: Hinge Health SEC Filings These filings provide detailed information on Hinge Health's financial performance and are considered the primary source of verified financial data for publicly traded companies.
Hinge Health (HNGE) does not currently pay a dividend. Over the last twelve months (LTM), the company paid $0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future.
Analyst assessments of whether Hinge Health (HNGE) consensus price target is overvalued or undervalued are generally expressed relative to consensus valuation frameworks and price targets, rather than as an absolute judgment.Current share price: $44.29Consensus price target: $57.53Implied return: +33.06% An implied return above current levels indicates that, on average, analysts view the stock as trading below their estimated fair value. Conversely, an implied return below current levels suggests the stock may be fully valued or priced above consensus expectations. This content is for informational purposes only and does not constitute investment advice. Last updated: April 24, 2026 at 4:23 PM Eastern Time
Based on the latest available analyst coverage, Hinge Health (HNGE) currently carries a Outperform consensus rating. Analysts' average HNGE price target is $57.53. Relative to the current share price of $44.29, this suggests a potential price change of approximately +33.06%. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: April 24, 2026 at 4:23 PM Eastern Time
Like other publicly traded stocks, Hinge Health (HNGE) shares are bought and sold on stock exchanges such as NYSE and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Hinge Health (HNGE) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.
At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add HNGE to your watchlist.
Hinge Health trades under the ticker symbol HNGE on the NYSE stock exchange. The ticker HNGE is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.
As of the most recently reported period, Hinge Health (HNGE) employs approximately 1,437 people worldwide. Reported employee figures may fluctuate over time due to hiring activity, restructuring, automation initiatives, or changes in business strategy. Headcount data is typically disclosed in company filings and reflects full-time employees unless otherwise stated. Last updated: April 23, 2026 at 6:09 PM Eastern Time
Hinge Health (HNGE) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest Hinge Health (HNGE) stock peers based on overlapping products, services, and competitive dynamics:Doximity (DOCS)Omada Health (OMDA)Veeva Systems (VEEV)LifeStance Health Group (LFST)Talkspace (TALK)Privia Health Group (PRVA)Hims & Hers Health (HIMS)Astrana Health (ASTH) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to Hinge Health.
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data Providers